MAP2K7 and hepatocellular carcinoma: Moreover, targeting MEK with PD-0325901 had in vivo chemopreventive effects on HCC development in an animal model employing TGF-alpha-transgenic mice in which liver cancers were induced by diethylnitrosamine treatment [82].